pk-china-user Shenlian Biomedical, the Gwadar Chamber of Commerce and Industry, and Sino Pharma Pvt Ltd signed a tripartite cooperation agreement in Shanghai on Thursday to jointly develop the foot-and-mouth disease (FMD) vaccine market in Gwadar and other designated areas of Balochistan.
The agreement was signed during a visit by the secretary to the president of the Gwadar Chamber of Commerce and Industry to Shanghai Shenlian Biomedical. During the visit, both sides also discussed plans to establish a joint animal vaccine laboratory in Gwadar.
Speaking to Gwadar Pro, James Shen, Head of the Overseas Business Department at Shenlian Biomedical, said that under the three-year agreement, Shenlian Biomedical will provide FMD vaccines, technical support, and compliance assistance. The Gwadar Chamber will facilitate regional market development, mobilize local resources, and coordinate with relevant authorities, while Sino Pharma Pvt Ltd, also known as Celer Farm, will act as the exclusive regional commercial agent.
“The initial focus of the cooperation will be on the supply and market development of a South African Type 1 FMD vaccine series for livestock, including sheep, beef cattle and dairy cattle,” he said.
He added that the Gwadar Chamber would utilize its local industrial, commercial, and livestock-sector networks to support market promotion, channel development, and outreach to end users. It will also help coordinate with local agriculture and livestock authorities, as well as other regulatory bodies, to facilitate product registration and market access.
Under the agreement, securing the necessary registration and market-access approvals will be a priority before commercial promotion and sales begin. The three parties will also exchange market information, including demand trends, competitor pricing, and tender updates, to support their sales and marketing strategies.
The agreement initially covers the Gwadar region and specified areas of Balochistan, although the partners may consider expanding their cooperation to other parts of Pakistan and eventually to neighbouring South Asian markets.
The proposed joint animal vaccine laboratory in Gwadar could further strengthen China-Pakistan cooperation in animal health, veterinary technology, and livestock development.
The three parties said they would work in accordance with the principles of equality, mutual benefit, long-term commitment, and compliant operations to establish a stable and sustainable cooperation mechanism. The agreement will remain valid for three years, with renewal given priority if the project remains profitable and no material breaches occur.
